In our study, we found that NGR1 down-regulated RUNX2 to enhance MDA and Fe2+ levels and promote oxidative stress and iron ion accumulation in breast cancer cell lines, and NGR1 was also able to activate oxidative stress to inhibit cell growth and invasion in nasopharyngeal carcinoma [24]. Here, RUNX2 is linked to breast cancer.